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e.2012.08Abstract Introduction: Benign prostatic hyperplasia (BPH) and prostatic carcinoma (Pca) are the
commonest diseases of the prostate with increased morbidities all over the world along the past few
years. Recent studies showed that DWI might be an effective adjunct tool in the localization and
potential treatment of prostate cancer with its ability to differentiate the cancer prostate from other
benign neoplastic and inﬂammatory conditions.
Objectives: In the current study we evaluated the role of the diffusion weighted MRI in the detec-
tion, localization and staging of cancer prostate.
Methods: Thirty male patients suspected to have prostate cancer were referred from the Urogenital
Surgery outpatient clinic to the department of Radio-diagnosis, Alexandria Main University Hos-
pital for radiological evaluation in the time interval from 1/1/2010 to 1/4/2011. Conventional and
DWI MRI studies for evaluation of the prostate were done. For Histopathological evaluation, tar-
geted trans-rectal US-guided biopsies were taken.
Results: According to MRI signals and presentations, in our study, 25 patients had peripheral zone
lesions (19 isolated peripheral zone and 6 mixed peripheral and central zones). Regarding central
zone lesions (5 cases), in four patients proved to have central gland adenocarcinoma and one patient
with adenomatous hyperplasia.com (Ahmad Hafez Ahmad
(A.N. Etaby), youssif_m@
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58 A.H.A.A. Aﬁﬁ et al.Analysis of data in the receiver operator characteristic curve yielded sensitivity of 100%, 95.83%
speciﬁcity, 95.83% PPV, 97% NPV and 97.87% accuracy for a cut-off value of 1.2 · 103 mm2/s
for detection of Pca in the PZ. In the CG the sensitivity for detection of Pca foci was 98.2%, spec-
iﬁcity 93.24%, PPV 91.67%, NPV 95% and accuracy 96.8% for a cut off value of 1.0 · 103 mm2/s.
Conclusion: Diffusion MRI is a helpful recent modality in diagnosis and staging of prostatic car-
cinoma.
ª 2012 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Prostate cancer is the most common non-cutaneous cancer
among males, accounts for 10% of cancer-related deaths in
males and hence, the diagnosis and treatment of prostate can-
cer continues to evolve.1 Of prostate cancer cases, 70% arise in
the peripheral zone, 15–20% arise in the central zone, and 10–
15% arise in the transitional zone.2 (Table 1).
MR imaging is a powerful imaging modality for compre-
hensive structural evaluation of anatomy and pathology of
the prostate gland and seminal tract. Its strengths are related
to high soft tissue contrast resolution, high spatial resolution,
and a lack of ionizing radiation, whereas the limitations of
conventional MRI are related mainly to its cost, insensitivity
for the detection of pathology at the molecular level and fre-
quent non speciﬁcity of structural imaging abnormalities that
are encountered.3
Conventional MRI was considered as an excellent technique
for the detection of Pca especially by using T2WI which clearly
able to distinguish the normal peripheral zone (PZ) and central
zone of the gland.4 MR imaging has been found to be more
accurate than either DRE or TRUS-guided biopsy for cancer
detection and localization.5,6 On the other hand, due to the
similarity in signal intensity between prostatic carcinoma and
benign prostatic hyperplasia on T2-weighted imaging as well
as difﬁcult evaluation of transitional zone prostate cancer, the
usefulness of conventional MRI is limited.6
So beneﬁts of conventional MRI (mainly using T2WI) are
predominantly limited to staging for the presence of extra-
capsular extensionand seminal vesicle invasion.5,6 InT1-weightedWI.
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Value of diffusion weighted magnetic resonance imaging in the prediction of cancer prostate 59All examined patients agreed to participate in the study and
provided with informed consent to use medical records for
research.
Each patient was subjected to full clinical evaluation, DRE,
and estimation of prostate speciﬁc antigen (PSA) level.
Regarding radiological studies; previous imaging modalities
including plain KUB, gray scale and power Doppler ultraso-
nography, IVU, CT or any other imaging modality were
checked. Conventional T2 W-MRI followed with DWI,
ADC mapping were done.
For Histopathological evaluation, targeted trans-rectal
US-guided biopsies were done (from suspicious lesions seen
on the DWI either detected on the TRUS and the conventional
MRI or not). Also, sextant biopsies (6–12 biopsies) including
bilateral upper, middle and lower prostatic zones were
done in the Intervention Unit of the Radiology department
(12 cases) and in Urology department (18 cases)
2.1. Technique and parameters
No speciﬁc patient preparation was needed for MRI examina-
tion. The patients were laid supine with arms beside the body
and the feet were introduced ﬁrst. Ten patients were examined
through a 1.5 T closed magnet MRI scanner (Gyroscan
Intera-Philips medical system-Netherlands) using phased
array surface body coil of 4 channels. The other 20 patients
were examined through a 1.5 T closed magnet MRI scanner
(Avanto-Siemens-Erlangen-Germany) using phased array
surface body coil (TORSO)-16 channels. Scans were obtained
from the pelvic inlet to the pelvic outlet. MRI was done before
biopsy in all cases. After routine MRI (axial, coronal and
sagittal) T2-weighted images, axial diffusion-weighted images
were acquired and then ADC values were calculated.
DWI imaging is typically performed with at least two B val-
ues (0–1000 s/mm2) to allow calculation of the ADC. Imaging
with low B values provides a higher signal-to-noise ratio
(SNR) but with less diffusion weighting. As the B value is in-
creased, sensitivity to the effects of diffusion increased, but at
the expense of a longer echo time, a worse SNR, and greater
image distortion. The lowest mean ADC value was taken after
measuring the ADC value in different areas. The ROI is ﬁtted
in a homogenous area averaging about 0.5 cm2 (changeable
depending on lesion size). ADC value was measured in the
suspected malignant area as well as the normal appearing
peripheral zone and normal appearing central zone.
2.2. Statistical analysis of the data
Data were analyzed using SPSS software package version 18.0
(SPSS, Chicago, IL, USA). Quantitative data were expressed
using Range, mean, standard deviation and median while
Qualitative data were expressed in frequency and percent.
Qualitative data were analyzed using Mann Whitney test for
comparing two groups.
Pearson coefﬁcient was used to analyze the correlation
between any two variables. Agreement of different predictive
with outcome was used and was expressed in sensitivity, spec-
iﬁcity, positive predictive value, negative predictive value,
accuracy and likelihood ratio. Receiver operating characteris-
tic curve (ROC) was done where the area under the ROC curve
denotes the diagnostic performance of the test. Area more than50% gives the acceptable performance and area about 100% is
the best performance for the test. p Value was assumed to be
signiﬁcant at 0.05.
3. Results
Digital rectal examination (DRE) was performed to all pa-
tients. Seven patients had right sided hard nodule, ﬁve patients
had left sided hard nodule and the other 18 patients had suspi-
cious rectal examination with no deﬁnite nodules felt. DRE
ﬁndings were used as a guide to the site of the lesion on the
MR images.
High PSA level was the main including criterion where it
ranged from 2.5 to 468 ng/ml. The mean PSA level was 67.5
(±12.6) ng/ml, where the largest group had a PSA level less
than 10 ng/ml (9 patients). Only one patient had a PSA level
of 2.5 ng/ml and he was included in the study because of sus-
picious DRE and unrelieved LURTS. Two patients had upper
limit of the normal value (5 ng/ml).
After laboratory, clinical and imaging evaluation, prostate
cancer was detected in 27 patients (90%), adenomatous hyper-
plasia in two patients (6.6%) and prostatitis (3.3%) in one pa-
tient. The majority of the lesions (19 patients) were in the
peripheral zone, in ﬁve patients there were isolated central
gland lesions while in six patients the lesions were seen involv-
ing both zones.
Conventional MRI was done for all patients (mainly
screening T2WI) to depict the hypointense area in the periph-
eral zone or suspicious nodule in the central gland, if present,
and correlated it with DW images and hence localized areas
needed for measuring ADC values.
According to MRI signals and presentations, in our study,
25 patients had peripheral zone lesions (19 isolated peripheral
zone and 6 mixed peripheral and central zones), 22 of them
showed hypointense T2 signal compared to the hyperintense
peripheral zone and proved to be adenocarcinoma, other one
had hypointense signal on T2WI in the peripheral zone and re-
vealed to be prostatitis (false positive case) as well as the
remaining two was proven to be adenocarcinoma and they
did not appear on the T2WI.
Regarding central zone lesions, in three patients proved to
have central gland adenocarcinoma, the lesion was not de-
picted on T2WI (false negative) and in one patient had a sus-
picious ill-deﬁned central gland nodule conﬁrmed by the DWI
and the pathology to be adenomatous hyperplasia (again false
positive case). One remaining case was depicted to have the
central gland well deﬁned hypointense nodule and proved to
be malignant with other conﬁrmatory modalities.
In the isolated peripheral zone lesions (19 patients) (exam-
ple at Figure 1), the commonest ﬁnding was the presence of
hypointense T2WI lesion on a background of normal hyperin-
tense peripheral zone without characterization of the nature of
the lesion in 15 patients. On DWI, 14 of them, proved to be
carcinomas, showed restricted diffusion (seen as hyperintense
on the highest used b value image, hypointense on the ADC
map) with a corresponding low measured ADC value ranging
from 0.5–0.97 · 103 mm2/s. The mean ADC value was 0.73
(± 0.14) · 103 mm2/s. The remaining one case of the hypoin-
tense lesions seen on the T2WI, was not restricted as hypo-
intense signals on the DWI and relatively hypointense in
ADC map and the measured ADC value was borderline at
Figure 1 80 year male had a RT hard nodule felt on DRE. PSA was 9.6 ng/ml. Axial T2WI (A) shows a hypointense right PZ lesion with
intact overlying hypointense capsule. The lesion is restricted as hyperintense signals on the axial DWI (b value 800) (B), hypointense on the
ADC map (C) and lowest mean ADC value was 0.68 · 103 mm2/s (ADC value on the left unaffected PZ was 1.6 mm2/s). Proved after
biopsy to be adenocarcinoma Gleason score 6.
60 A.H.A.A. Aﬁﬁ et al.1.2 · 103 mm2/s. After TRUS guided biopsy it revealed to be
granulomatous prostatitis.
DWI depicted two peripheral zone lesions as restricted dif-
fusion with consequently low ADC value which were not seen
on the T2WI as they were isointense to the PZ raising the sen-
sitivity of diffusion MRI in depicting lesions compared with
routine MR imaging (Figure 2).
Two other patients had hypointense peripheral zone lesions
on T2WI but their borders, extent and involvement of one orFigure 2 83 year male had a hard RT nodule by DRE.PSA was 9 n
ROI around the right bulky PZ in (B),which is seen restricted, hyperin
map (D), the lowest mean ADC value was 0.58 · 103 mm2/s (RO
1.2 · 103 mm2/s Targeted biopsy from RT side was done, proved toboth lobes were ill-deﬁned and they were well deﬁned as
restricted area on the DWI with a corresponding low ADC
value.
In Central gland lesions (5 patients), a hypointense lesion
was suspected on T2WI on a background of heterogeneous sig-
nal of the central gland (characterization on T2WI was difﬁcult
as a hyperplastic or a malignant nodule in the presence of het-
erogeneous gland). However on DWI the lesions were re-
stricted (hyperintense on the highest b value and hypointenseg/ml. Axial T2WI (A and B) showed bulky isointense right PZ (A
tense on the axial DWI(b value800) (C), hypointense on the ADC
I 1) and the mean ADC value in the left unaffected PZ was
be adenocarcinoma Gleason score 8.
Value of diffusion weighted magnetic resonance imaging in the prediction of cancer prostate 61on the ADC map) and proved histopathologically to be of
malignant nature.
DWI depicted another two central gland lesions as restricted
diffusion (hyperintense on the DWI and hypointense on the
ADC map) with low ADC value which measured 0.76 and
1 · 103 mm2/s. These lesions were seen as intermediate signal
on T2WI, isointense to the surrounding central gland. (FigureFigure 3 76 year male with LUT symptoms and PSA was 100 ng
occupying most of the prostate (mostly originating of the CG), its natu
restricted, hyperintense on the axial DWI (B) (b value 1000), hypointen
0.619 · 103 mm2/s in the restricted nodule. Proved to be adenocarcin
Figure 4 50 year male patient presented with LURTS, high PSA lev
T2WI (A) shows hypointensity in the medial parts of both PZs with ano
were restricted, hyperintense on the axial DWI (B) (b value 800), hypo
0.7 · 103 mm2/s in both areas. Biopsies obtained by TRUS showing3) DWI excluded malignancy in two other cases proved histop-
athologically to be adenomatous hyperplasia, the ﬁrst one
showed slightly hyperintensity on the highest b value but also
hyperintense on the ADC map (T2 shine through) with aver-
age measured ADC value (1.2 · 103 mm2/s). The other case
had a heterogeneous signal of the central gland on T2WI but
no restricted foci at DW images./ml. Axial T2WI (A) shows isointense large well deﬁned nodule
re could not be assessed based on the T2WI only. The lesion was
se on the ADC map (C). Lowest mean ADC value measured was
oma Gleason score 9 with perineural invasion.
el 66 ng/ml and DRE revealed right hard prostatic nodule. Axial
ther well deﬁned iso to hypointense nodule of the CG. Both lesions
intense on the ADC map (C) with lowest mean ADC value about
adenocarcinoma Gleason score 6(3 + 3).
62 A.H.A.A. Aﬁﬁ et al.In Combined peripheral and Central gland lesions (6
patients) where the peripheral zone component was depicted
as hypointensity on T2WI while central gland involvement
was seen as hypointensity continuous with the peripheral zone
lesion in two patients (Figures 4 and 5) and isointense in four
patients ( Figure 6). DWI conﬁrmed restricted diffusion in
those cases with low ADC value which were conﬁrmed to be
prostatic adenocarcinoma.
DWI depicted Pca foci as restricted diffusion (hyperintense
on the highest used b value image and hypointense on the
ADC map, which was seen in 25 out of 27 patients with proved
Pca (e.g. Figures 1 and 2). However, in two other patients with
proved Pca there was no evident hyperintensity on the DWI
but still hypointense on the ADC map (Fig. 4).
In cases that were proved not to be malignant, no hyperin-
tensity was seen on the DWI in two patients and one patient
showed hyperintensity on both DWI and ADC map (T2 shine
through).
Technically, the cases done using phased array abdominal
surface coil of 4 channels on the Philips (Gyroscan-Intera
1.5 T scanner) provided lower signal to noise ratio compared
to the cases done using the 16 channel coil on the Siemens
(Avanto 1.5 T scanner).Figure 5 50 year male patient complained of LURTS and perineal pa
of the PZ, most of the CG and the right SV. The lesions were restricted
the ADC map (C). (The diffusion also conﬁrmed involvement o
0.74 · 103 mm2/s in (G). Mean ADC value of the spared part of the le
a restricted left external iliac LN with average ADC value of 0.7 · 10Analysis of data in the receiver operator characteristic
curve yielded sensitivity of 100%, 95.83% speciﬁcity, 95.83%
PPV, 97% NPV and 97.87% accuracy for a cut-off value of
1.2 · 103 mm2/s for detection of Pca in the PZ. In the CG
the sensitivity for detection of Pca foci was 98.2%, speciﬁcity
of 93.24%, PPV of 91.67%, NPV of 95% and accuracy of
96.8% for a cut off value of 1.0 · 103 mm2/s.
ADC values obtained from foci of Pca using b values (0,
500, and 000) did not differ signiﬁcantly from those obtained
using b values (50,400,800) (p value was 0.11, >0.05).
An inverse relationship was found between the ADC value
and the Gleason score in the current study which can predict a
high or low grade tumor. There was a signiﬁcant statistical dif-
ference between the mean ADC value measured for Gleason
score P7 (high grade) and score 66 (low grade) (p= 0.019).
The mean ADC value of cases with Gleason score P7 was
0.67(±0.14) · 103 mm2/s and for those 6score 6 was 0.81
(±0.14) · 103 mm2/s.
Signs of extraprostatic extensions were surveyed as inter-
ruption of the hypointense T2 prostatic capsule, involvement
of the neurovascular bundles and the denovillier’s fascia as
well as invasion of the rectum, urinary bladder neck and
seminal vesicle. Seminal vesicles’ invasion was noted as intra-in. Axial T2WIs (A) shows large hypointense lesion involving most
, hyperintense on the Axial DWIs (b value 800) (B), hypointense on
f the CG and right SV). The lowest mean ADC value was
ft PZ was 2 · 103 mm2/s. Axial DWI (D) and ADC map (E) show
3 mm2/s (conﬁrmed to be malignant node).
Value of diffusion weighted magnetic resonance imaging in the prediction of cancer prostate 63vesicular T2 hypointense signals continuous with the primary
tumor. (Figure 7)
Identifying local extensions of a tumor aided in the local
staging. If the capsule is not involved which means we are still
dealing with a T2 tumor (Figure 1), once the capsule is inter-
rupted this denotes a T3 (T3a unilateral interruption, T3b
bilateral interruption (Figure 4) and T3c invading the seminal
vesicle (Figure 5). Involvement of the urinary bladder or rec-
tum means a T4 tumor.
Some areas of loco-regional extensions could not be con-
ﬁrmed on the conventional T2WI which was veriﬁed on the
DWI as restricted diffusion (hyperintensity) on the DWI with
a corresponding low ADC value.
4. Discussion
Although the sensitivity of T2 weighted images for tumor
detection is high, speciﬁcity is poor.10 Low signal intensity
within the peripheral zone on T2-weighted images also can
be seen in other non-neoplastic etiologies such as prostatitis,
post-biopsy hemorrhage, post-irradiation ﬁbrosis, and follow-
ing hormonal therapy.10,11 Furthermore, the tumors that occur
in the central gland (30%) are difﬁcult to be detected on T2
weighted imaging because it is not possible to differentiate
them from the low signal-intensity and heterogeneous benign
nodules of prostatic hyperplasia.12
In the current study, we evaluated the role of DWI in the
detection of prostate cancer which yielded high sensitivity
and speciﬁcity, compared to the conventional MRI, in combi-
nation with PSA level, DRE and histopathological analysis.
High PSA level was the ﬁrst step for raising suspicion for
cancer followed with updated radiological imaging studies,
however, 14 patients had PSA level below 20 ng/ml, 10 of themFigure 6 59 year male patient presented with hard left nodule. PSA
which corresponds to the ﬁndings on DRE, a suspicious bulky isointe
veriﬁed on the T2WI only. Both lesions were seen restricted, faintly hy
ADC map (C) ADC values were respectively 0.57 · 103 and 0.76 ·
Gleason score 6 on the right CG nodule and score of 7 on the left PZhad PSA level below 10 ng/ml. This entails the important role
of imaging to detect cancer prostate in the absence of signiﬁ-
cant PSA elevation. DRE was also positive in 13 patients
and was correlated to the images.
Regarding conventional MR images, Gupta et al.13 stated
that T1WI is used mainly for the detection of post biopsy hem-
orrhage if biopsy preceded MRI to avoid misinterpretation as
prostate cancer, whereas Yu et al.14, stated that T2 images
showed cancer as hypointense area relative to normal periph-
eral zone tissue due to increased cell density and loss of pros-
tatic ducts.
Recently, Woodﬁeld et al.15 stated that, MRI of prostate
cancer with conventional T2-weighted imaging is predomi-
nantly limited to staging for the presence of extra-capsular
extension and seminal vesicle invasion. Concomitantly,
Yoshizako et al.16 reported that, transition zone cancer detec-
tion (30%of all prostate cancer) is difﬁcult due to the prevalence
of BPH heterogeneous nodules with undifferentiated TZ
cancer from BPH nodules on T2 or enhanced MRI.
In the current study, conventional T2WI role in the detec-
tion of pathology revealed a sensitivity of 88.6%, speciﬁcity
of 75%, PPV of 95.8%, NPV of 50% and accuracy for detec-
tion was 86.6% .Whereas the study done by Haider et al.17
showed that, the sensitivity of T2-weighted imaging alone for
the whole prostate was relatively lower at 54% and speciﬁcity
was higher at 91%.
Researchers such as Yoshimitsu et al.18 reported that, the
more recent application of functional MRI techniques, includ-
ing DWI, has the potential to expand the role of MRI to non-
invasive characterization of prostate cancer by providing more
speciﬁc information regarding tumor location, size, and
aggressiveness. He studied 37 cancer prostate patients per-
formed on a 1.5 T magnet with pelvic phased array surfacewas 69.3 ng. Axial T2WI (A) revealed left PZ hypointense lesion
nse nodule to the CG is noted however its character could not be
perintense on the axial DWI (b value 800) (B) hypointense on the
103 mm2/s. Histopathologically proved to be adenocarcinoma
nodule.
Figure 7 55 year male patient. Axial T2WI (A), show a hypointense lesion involving the right PZ as well as diffuse hypointensity of the
CG. Axial DWIs (B) show restricted diffusion (hyperintensity) of the right PZ with minimal encroachment on the left side of the CG
(however the hypointensty involving most of the CG on T2 was not restricted). ADC map (C) reveals hypointensity of the previously
noted lesion. The lowest mean ADC value was 0.73 · 10–3 mm2/s. Axial T2WI (D) shows a hypointense focus at the right SV (suspected
invasion) which was conﬁrmed as restricted diffusion on the ADC map (E).
Table 2 Comparison between ADC values in malignant
lesions and in normal peripheral and central zones.
ADC value Lesion Peripheral zone Central gland
Number 27 24 21
Range 0.50–1.1 1.20–2.0 1.0–1.50
Mean ± SD 0.74 ± 0.15 1.57 ± 0.19 1.23 ± 0.14
Median 0.74 1.55 1.20
Z1(p) 6.129 (<0.001)
* 5.839 (<0.001)*
Z2(p) 4.951 (<0.001)
*
Z1:Z for Mann Whitney test between lesion with peripheral and
central zones.
Z2:Z for Mann Whitney test between peripheral and central zones.
* Statistically signiﬁcant at p6.
64 A.H.A.A. Aﬁﬁ et al.coil, using b values of 0, 500, and 1,000 s/mm2, despite result-
ing in images with lower SNR, which can improve lesion
detection.
In this study, B values initially used were 0,500,1000 in ﬁve
patients aiming at suppression of all the background signals to
delineate the restriction however the signal to noise ratio was
low and measurements of ADC were difﬁcult in the image
due to low signal. Then in the rest of the 25 patients we used
the b value of 50,400,800 aiming at a better signal to noise ra-
tio which also provided good suppression of the background
signal with good delineation of the restriction.
On the other hand, Tamada et al.19 in their series of pa-
tients with prostate cancer, imaging was performed on a
1.5 T magnet without the use of an endorectal coil and using
800 s/mm2 as the highest b value.
We performed DWI technique without breath holding,
using a multi-channel phased array surface coil only, whereas
rectal coil was not used except in one patient who did not tol-
erate it resulting in motion artifacts. This agreed with Husband
et al.20 On the other hand, Kim et al.21 reported that endorec-
tal coil provides a superior signal-to-noise ratio (SNR) but
causes reduced patient compliance and increased susceptibility
effects, whereas, the pelvic phased-array coil results in a rela-
tively inferior SNR, which may be overcome by increasingthe number of averages used in imaging, however, this com-
pensatory strategy results in a longer image acquisition time.
Also, Turkeby et al.22 added that endorectal coils provide large
gains in signal with reductions in noise, most noticeably at
1.5 T; however, endorectal coils are uncomfortable and
expensive.
The considered criterion for the diagnosis of cancer pros-
tate in our study was hyperintense lesion on DWI on
Table 3 Summary of the combination between MRI T2 signals, diffusion restriction and histopathological correlation.
Lesions T2 WI signals Restriction in DWI Histo-pathological
correlation
Peripheral zone lesions
(19 patients)
14 Hypointense Restricted diﬀusion Adenocarcinoma
2 Ill def. margins hypointense Restricted well deﬁned in diﬀusion Adenocarcinoma
1 Hypointense Not restricted Granulomatous
Prostatitis
2 Not deﬁned Restricted diﬀusion Adenocarcinoma
Combined peripheral
and central
zone lesions (6 patients)
All with peripheral hypo T2 component
where the central part is T2 hypointense in four
patients and isointense in two patients
All shows restricted diﬀusion All were
Adenocarcinomas
Central zone lesions
(5 patients)
1 Hypo intense and two intermediate signals Restricted diﬀusion Adenocarcinomas
2 Heterogenous T2 signals One not restricted, one T2 shine through Adenomatous
hyperplasia
Table 4 Relation between different b values and ADC values.
B Value
50,400,800 0,500,1000
Number 24 3
ADC value Range 0.50–1.10 0.59–0.65
Mean ± SD 0.76 ± 0.16 0.62 ± 0.03
Median 0.76 0.62
Z (p) 1.587 (0.112)
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Ren et al.23 and Koh et al.24 reported that in Pca, higher signal
intensity on DWI and lower ADC compared with BPH nodule
and normal tissue is explained with the replacement of normal
tissue (composed of water rich acinar structures) by densely
packed malignant epithelial cells within small amount of
stroma, associated with increased nucleus-to-cytoplasm ratio,
resulting in extremely reduced motility of water molecules.
On the other hand, another recent study by Woodﬁeld
et al.15 revealed that, the criterion for benign prostate tissue
was the absence of hyperintensity on the DWI sequence and
absence of hypointensity on T2-weighted images in the periph-
eral zone at a site of biopsy-proven benign tissue. DWI was
able to discriminate normal prostate gland, benign prostatic
hyperplasia (BPH) nodules, cysts, and carcinoma as lack of
hyperintensity with no hypointensity on ADC maps and aver-
age ADC value according to the zone, was considered as be-
nign prostatic tissue (Table 2).
In 24 patients in our study that proved to be cancer prostate
had hyperintense foci on the DWI and hypointense on the
ADC map with corresponding low ADC value compared to
the adjacent peripheral or central glands according to its site.
This was true except in two cases that proved to be cancer
prostate with no hyperintensity in the DWI but with a corre-
sponding low ADC value, may be due to marked hypointense
signal on the T2WI (T2 black out effect).
In our study the mean ADC value measured in normal cen-
tral zone in 21 patients was 1.23 ± 0.14 mm/s (ranging from
1–1.5 mm/s) and the mean ADC value from the normal
peripheral zone measured in 24 patients was 1.57 ± 0.19. That
was matched with Gibbs et al.25 who reported that, the normal
central gland of the prostate has a lower ADC than the periph-
eral zone (Table 3).
Comparison between ADC values obtained from cancer
foci, normal peripheral and central glands using a b value of
0,500,1000 did not differ signiﬁcantly from those using b of
50,400,800. Using the b value 0,500,1000 had a lower ADC va-
lue in cancer foci and peripheral zone but was not signiﬁcant,
however in both there was a signiﬁcant difference between can-
cer foci and normal peripheral and central glands. There is
some overlap between ADC values measured in malignant cen-
tral zone and in the peripheral zone, may be due to the small
number of patients with central gland cancer and some pa-
tients were examined with different b values.In our study addition of DWI to the conventional MR
images lead to increased sensitivity and speciﬁcity compared
to the use of conventional MRI (T2WI only) 96.1% and
100% respectively. PPV was 100%, NPV was 80% and accu-
racy for detection was 96.6% for a cut off value of 1.1 mm/s
to differentiate benign from malignant lesions in a ROC curve.
Haider et al.17 had reported that T2-weighted imaging com-
bined with DWI is better than T2-weighted imaging alone as
addition of DWI to T2WI improved sensitivity from 54% to
81%. Kumar et al.26 reported that, DWI seems to perform bet-
ter in localization of prostate carcinoma candidate for biopsy,
compared with T2WI (Table 4).
DWI helped in the detection of questionable extracapsular
invasion of the seminal vesicles and bladder neck. This was
conﬁrmed in 10 patients in our study as areas of restricted dif-
fusion. In elderly men, atrophic changes in the seminal vesicles
can render the entire seminal vesicle low in signal on T2-
weighted imaging, thus interfering with the diagnosis. Also
DWI had a role in the conﬁrmation of bony metastatic lesion
which appeared to be heterogeneous on T1 and T2WIs, by
apparently being restricted and of low ADC value, the ones
measured in our study was around 5.5 mm2/s.
Additional beneﬁt of DWI is the ability to determine indi-
ces, which may be important in the assessment of disease re-
sponse to treatment methods. Conventional assessment by
measuring lesion size is insensitive to early treatment-related
changes.
The presence of lymph nodal metastases in newly diagnosed
patient or recurrent prostate cancer is an important prognostic
factor leading to greater risk for progression, distant metasta-
ses, and death27–29 and that up to 80% of the lymph node
metastases can be located in normal sized (8 mm) lymph
66 A.H.A.A. Aﬁﬁ et al.node.30 They suggest that the ADC value could be a promising
tool for differentiating benign from malignant nodes in pros-
tate cancer patients and are signiﬁcantly more accurate than
size criteria.31
Finally, regarding study limitations that can be summa-
rized as non use of endo-rectal coil that promised to yield
high resolution MR data, application of different b values
(b value of 0,500,1000 in ﬁve patients and 50,400,800 in
25 patients), targeted biopsies were not done in all patients,
comparison with other functional MR imaging such as
dynamic contrast-enhanced MRI or MR Spectroscopy was
not performed (which yield more accurate detection of
prostate cancer).
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